Evidence map›Paper›PMID 42506187›Full record

ReviewMembranes2026

Advantages of Protein A Membrane Chromatography: High Productivity, Strong Impurity Removal Capability, and More.

Yifeng Li, Hang Zhou, Sherry Gu

Abstract readReview
In one paragraph

Review in Membranes, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Yifeng LiDownstream Process Development (DSPD), WuXi Biologics, 31 Yiwei Road, Waigaoqiao Free Trade Zone, Shanghai 200131, China.ORCID 0009-0002-6994-9276
Hang ZhouBioprocess Research and Development (BRD), WuXi Biologics, 31 Yiwei Road, Waigaoqiao Free Trade Zone, Shanghai 200131, China.
Sherry GuGlobal Biologics Development and Operations (GBDO), WuXi Biologics, 31 Yiwei Road, Waigaoqiao Free Trade Zone, Shanghai 200131, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Protein A affinity chromatography is the gold standard for antibody purification. In practice, it is mainly performed using resin-based packed bed columns. However, for porous resins, mass transport depends on slow diffusion and, consequently, low flow rates/long residence times are required to achieve decent binding capacities (i.e., >30 mg/mL), which leads to long processing time and low productivity. Recently, Protein A membranes have emerged as a promising alternative to Protein A columns. Membrane adsorbers, which have large pores, enable convection-based mass transport and allow high dynamic binding capacity to be achieved at a relatively short residence time (on the order of seconds). Hence, Protein A membranes can be operated at high flow rates and gain significantly improved productivity. In addition to high productivity, we recently found that Protein A membranes possess a much stronger impurity-removing capability than Protein A columns. This review introduces the advantages that Protein A membrane chromatography offers, especially those that have not been well recognized before. These advantages allow high-quality products to be obtained with significantly reduced costs.

Indexed as

aggregateflexibilityhost cell protein (HCP)productivityProtein A membranerobustness

Identifiers

PMID42506187
PMCPMC13414297

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.